← Back
$APGE All transactions

Apogee Therapeutics, Inc.

A

$ Value

$0

Shares

14,461

Price

$0

Filed

Jun 20

Insider

Name

Fairmount Funds Management LLC

Title

CIK

0001802528

Roles

Director

Transaction Details

Transaction Date

2025-06-17

Code

A

Table

Derivative

Ownership

Indirect

Equity Swap

No

Shares After

14,461

Footnotes

This option represents the right to purchase 14,461 shares of the Issuer's common stock and will vest on the one-year anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer on such vesting date. | Under Mr. Harwin's arrangement with Fairmount Funds Management LLC ('Fairmount'), Mr. Harwin holds the option for one or more investment vehicles managed by Fairmount (each, a "Fairmount Fund"). Mr. Harwin is obligated to turn over to Fairmount any net cash or stock received from the option for the benefit of such Fairmount Fund. Mr. Harwin therefore disclaims beneficial ownership of the option and underlying common stock. Fairmount disclaims beneficial ownership of any of the reported securities, except to the extent of its pecuniary interest therein. | Under Mr. Kiselak's arrangement with Fairmount, Mr. Kiselak holds the option for one or more Fairmount Funds. Mr. Kiselak is obligated to turn over to Fairmount any net cash or stock received from the option for the benefit of such Fairmount Fund. Mr. Kiselak therefore disclaims beneficial ownership of the option and underlying common stock. Fairmount disclaims beneficial ownership of any of the reported securities, except to the extent of its pecuniary interest therein.

Filing Info

Accession No.

0001104659-25-061278

Form Type

4

Issuer CIK

0001974640

Fairmount Funds Management LLC's History

Date Ticker Type Value
2026-03-31 COGT C
2026-03-31 COGT $242.6M
2026-03-31 COGT C $0
2026-03-31 ZBIO $3.0M
2026-03-23 DMRA A $0
2026-02-09 GLTO M $0
2026-02-09 GLTO M $0
2026-02-09 GLTO M $0
2026-02-09 GLTO M $0
2026-01-22 APGE $133.5M

Other Insiders at APGE (90d)

Insider Bought Sold Last
Henderson Jane
Chief Financial Officer
$652K 2026-04-16
HENDERSON MICHAEL THOMAS
Chief Executive Officer
$2.9M 2026-04-16
Dambkowski Carl
Chief Medical Officer
$828K 2026-04-01